![](/img/cover-not-exists.png)
Prediction of Clinical Responses in a Simulated Phase III Trial of Crohn's Patients Administered the Antisense Phosphorothioate Oligonucleotide ISIS 2302: Comparison of Proposed Dosing Regimens
Yu, Rosie Z., Su, John Q., Grundy, John S., Geary, Richard S., Sewell, K. Lea, Dorr, Andrew, Levin, Arthur A.Volume:
13
Language:
english
Journal:
Antisense and Nucleic Acid Drug Development
DOI:
10.1089/108729003764097340
Date:
February, 2003
File:
PDF, 177 KB
english, 2003